OTC labeling meeting postponed
This article was originally published in The Rose Sheet
Executive Summary
FDA/industry working group meeting scheduled for Nov. 1 postponed due to late submission of supporting docuemtns. Due to other commitments, FDA "personnel will not permit a shortened review time of the materials," the agency said. The first available date to reschedule the OTC labeling meeting is Nov. 23 from 10 a.m. to 12 p.m. Once FDA receives the supporting materials, it will outline an agenda
You may also be interested in...
OTC Label Trade Dress, Multiple Columns Need Quick Resolution - CHPA
The issues of columns and trade dress in the OTC labeling final rule "have lingered too long, and a response from FDA is urgently needed," the Consumer Healthcare Products Association asserts in an Oct. 22 letter to the agency.
OTC Labeling Final Rule Two-Year Extension Requested By CTFA
A stay of implementation of the OTC labeling final rule would allow industry and FDA to address outstanding issues, the Cosmetic, Toiletry and Fragrance Association says in an Oct. 22 citizen petition.
OTC Label Trade Dress, Multiple Columns Need Quick Resolution - CHPA
The issues of columns and trade dress in the OTC labeling final rule "have lingered too long, and a response from FDA is urgently needed," the Consumer Healthcare Products Association asserts in an Oct. 22 letter to the agency.